Lunai Bioworks (LNAI) Net Cash Flow (2011 - 2026)

Lunai Bioworks' Net Cash Flow history runs 16 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 27.65% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.4 million (up 13.28% YoY), while the FY2025 annual figure was $8125.0, up 100.47% from the prior year.
• Net Cash Flow was $2.7 million for Q1 2026 at Lunai Bioworks, up from -$122451.0 in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.7 million in Q1 2026 to a low of -$3.9 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$526446.1 across 5 years, with a median of -$357092.0 in 2023.
• Biggest YoY gain for Net Cash Flow was 4092.51% in 2025; the steepest drop was 153200.46% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$3.9 million in 2022, then surged by 90.73% to -$357092.0 in 2023, then surged by 108.75% to $31255.0 in 2024, then slumped by 491.78% to -$122451.0 in 2025, then soared by 2285.9% to $2.7 million in 2026.
• The last three Net Cash Flow figures came in at $2.7 million (Q1 2026), -$122451.0 (Q4 2025), and $538947.0 (Q3 2025), per Business Quant data.